In Vivo 2006-01-01

Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.

Zoltán Baráth, Rita Radics, Gabriella Spengler, Imre Ocsovszki, Masami Kawase, Noboru Motohashi, Yoshiaki Shirataki, Anamik Shah, József Molnár

Index: In Vivo 20(5) , 645-9, (2006)

Full Text: HTML

Abstract

Several new 3-formylchromone derivatives proved to be modifiers of multidrug resistance in mouse lymphoma cells and in human Colo320 colon cancer cells. There is apparently a structure-activity relationship between the antiproliferative multidrug resistance-reversing effect and the chemical structure of the 3-formylchromones. The total polar surface areas and the ground state dipole moments of the molecules are presumed to play a key role in the multidrug resistance-reversing effect. The log P values can provide an adequate explanation for the selective cytotoxicity against cancer cells.

Related Compounds

  • 6-bromo-3-formylch...
  • 6-chloro-3-formyl-...
  • 6-NITRO-4-OXO-...
  • 3-Formyl-6-isoprop...
  • 3-formyl-6-methylc...

Related Articles:

Discovery of new chromone containing sulfonamides as potent inhibitors of bovine cytosolic carbonic anhydrase.

2011-06-01

[Bioorg. Med. Chem. 19 , 3367-71, (2011)]

Biological activity of 3-formylchromones and related compounds.

2007-01-01

[In Vivo 21(5) , 829-34, (2007)]

A study of the reactions of 2-aryl-4-hydroxy-6H-1,3-thiazin-6-ones with chromone-3-carboxaldehydes. Shutov RV, et al.

[Tetrahedron Lett. 52(2) , 266-269, (2011)]

More Articles...